Imaging data from the CONTENTed study suggest the type 2 inflammation that drives severe asthma may affect more than the airways.
|Articles|January 13, 2022
Daily OTC Pearl: Nikzon Hemorrhoidal
Author(s)Saro Arakelians, PharmD
Nikzon Hemorrhoidal may temporarily relieve itching, burning, and discomfort associated with hemorrhoids.
Advertisement
OTC/Lifestyle Pearl of the Day: Nikzon Hemorrhoidal
Indication: Nikzon Hemorrhoidal is used for the temporary relief of anorectal itching, burning, and discomfort associated with hemorrhoids, anorectal disorders, inflamed hemorrhoidal tissues, or piles.
Insight:
- Ingredients: Phenylephrine hydrochloride 2.5 mg in 1 g, pramoxine hydrochloride 10 mg in 1 g.
- For external use only
- Caution: Do not put this product into the rectum by using fingers or any mechanical device or applicator.
- Directions: Remove cap and lift foil safety seal from tube.
- Adults: When practical, cleanse the affected area with mild soap and warm water, and rinse thoroughly. Gently dry by patting or blotting with toilet tissue or a soft cloth before application of this product.
- Apply externally to the affected area with a thin layer up to 4 times daily.
- Children under 12 years of age: consult a physician.
- Storage: Store at room temperature 15°-30°C (59-86°F).
Sources:
Advertisement
Related to this article
Renal benefit appeared only in patients with albuminuria in a 75,455-person BMJ analysis, while sulfonylureas signaled faster decline without it.
Authors of a pharmacist-directed transitions of care study discuss what drives pneumococcal vaccine hesitancy and how pharmacists can build systematic vaccine screening into inpatient workflows.
HYPERION trial data now support sotatercept within a patient's first year of pulmonary arterial hypertension (PAH) diagnosis, cutting clinical worsening risk by 76% compared with placebo.
A stewardship program combining EHR alerts and pharmacist-led education offers a replicable model for reducing bleeding risk.
Tim Cernohous of Cencora explains why patient trust no longer guarantees satisfaction—and how automation and better communication can close the gap with mail order.
Eight Humira biosimilars have been launched, but payer formularies and interchangeability rules decide what dispenses.
At NEIAP 2026, Kelsey Norman, PharmD, walked through how VESALIUS-CV, Lp(a)HORIZON, and CKM guidelines change pharmacist-led lipid care.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Armored CAR T-Cell Therapy Produces Durable Complete Response in Pediatric Solid Tumors
2
Semaglutide Linked to Up to 40% Fewer Asthma Attacks, Real-World Data Show
3
Not So Rare After All: Pharmacists Weigh In on Diagnosing and Managing ATTR-CM
4
After 180 Years, Multiple Myeloma Gets a Definition of Cure
5